Africa losing opportunities to reduce poverty because of ‘dysfunctional’ GM debate

Opportunities to enhance crop yields and reduce poverty in Africa are being lost because of a โ€œpolarised public debateโ€ on the continent, according to a report released 21 July by internationalย policyinstitute Chatham House.

Genetic modificationย (GM) research projects remain stuck at the field trial stage due to governmentsโ€™ fears keeping theย technologyย from Africanย farmers, it says.ย This โ€œdeadlockโ€ of continual field trials has allowed African governments to appease both sides of the GM debate: proponents are pleased research is done, whereas opponents are satisfied that research has not led to products on the market, the report says.

โ€œMany of the opponents of GM crops are not interested in engagement or understanding. They want to eliminate the technology altogether,โ€ says Calestous Juma, an international development expert at Harvard Kennedy School, United States.

In many African countries, the report says, governments face political damage for being perceived to be too pro-GM. Policymakers are reluctant to release biotechnologies due to fears of media campaigns or a backlash from civil society, it adds.ย The most important improvements needed, the report notes, are engaging farmers in research to understand their needs and making sure this research translates into impact.

Read the full, original article:ย GMโ€™s potential in Africa impeded by โ€˜dysfunctional debateโ€™

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesnโ€™t change the scienceโ€”the worldโ€™s most popular herbicide is safeย 
Picture1
The FDA couldnโ€™t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
global warming
โ€˜Implausibleโ€™: Top climate scientists reject worst-case scenarioโ€”soaring temperatures and fast-rising sea levels
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Screenshot-2026-05-21-at-3.15.53-PM
Chiropractors may no longer be modern-day snake oil salesmen, but the benefits of their therapy are limitedโ€“at best
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research showsโ€”but not for blacks and ethnic minorities
Screenshot-2026-05-20-at-5.11.17-PM
Viewpoint: No, sugar doesnโ€™t โ€˜feedโ€™ cancer โ€” common cancer myths, debunked

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.